Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toufigh Gordi

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|July 22, 2008
Artesunate for malariaToufigh Gordi
Expert Review of Clinical Pharmacology|March 7, 2012
Drug discovery and development: lessons from an undeveloped drugToufigh Gordi
The Journal of Pharmacy and Pharmacology|September 25, 2008
Artemisinin derivatives with long elimination half-lifeToufigh Gordi
Journal of Clinical Pharmacology|September 4, 2007
Comments on "Dual effects of rifampin on the pharmacokinetics of atrasentan"Toufigh Gordi
Clinical Therapeutics|June 29, 2004
Simple solution to a common statistical problem: interpreting multiple testsToufigh Gordi, Harry Khamis
British Journal of Clinical Pharmacology|May 19, 2007
Retrospective analysis of artemisinin pharmacokinetics: application of a semiphysiological autoinduction modelSara Asimus, Toufigh Gordi
Toxicology Letters|February 6, 2004
Artemisinin derivatives: toxic for laboratory animals, safe for humans?Toufigh Gordi, Eve Irene Lepist
Journal of Clinical Pharmacology|June 23, 2007
Regadenoson pharmacokinetics and tolerability in subjects with impaired renal functionToufigh Gordi, Brent Blackburn, Hsiao Lieu
British Journal of Clinical Pharmacology|November 25, 2005
Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisininToufigh Gordi, Rujia Xie, William J Jusko
Clinical Therapeutics|June 17, 2008
Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjectsToufigh Gordi, Eddie Hou, Sreeneeranj Kasichayanula, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|July 22, 2008
Artesunate for malariaToufigh Gordi
Expert Review of Clinical Pharmacology|March 7, 2012
Drug discovery and development: lessons from an undeveloped drugToufigh Gordi
The Journal of Pharmacy and Pharmacology|September 25, 2008
Artemisinin derivatives with long elimination half-lifeToufigh Gordi
Journal of Clinical Pharmacology|September 4, 2007
Comments on "Dual effects of rifampin on the pharmacokinetics of atrasentan"Toufigh Gordi
Clinical Therapeutics|June 29, 2004
Simple solution to a common statistical problem: interpreting multiple testsToufigh Gordi, Harry Khamis
British Journal of Clinical Pharmacology|May 19, 2007
Retrospective analysis of artemisinin pharmacokinetics: application of a semiphysiological autoinduction modelSara Asimus, Toufigh Gordi
Toxicology Letters|February 6, 2004
Artemisinin derivatives: toxic for laboratory animals, safe for humans?Toufigh Gordi, Eve Irene Lepist
Journal of Clinical Pharmacology|June 23, 2007
Regadenoson pharmacokinetics and tolerability in subjects with impaired renal functionToufigh Gordi, Brent Blackburn, Hsiao Lieu
British Journal of Clinical Pharmacology|November 25, 2005
Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisininToufigh Gordi, Rujia Xie, William J Jusko
Clinical Therapeutics|June 17, 2008
Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjectsToufigh Gordi, Eddie Hou, Sreeneeranj Kasichayanula, et al.
Pageof 3